Catheter ablation of atrial fibrillation in heart failure with reduced ejection fraction.
Nav MalhiNathaniel M HawkinsJason G AndradeAndrew D KrahnMarc William DeyellPublished in: Journal of cardiovascular electrophysiology (2018)
Atrial fibrillation and heart failure are increasing in prevalence, and frequently coexist. Despite the desire to restore sinus rhythm in heart failure patients, large studies comparing rate control to pharmacologic rhythm control have failed to show superiority of either approach. This may in part be due to the inefficacy and higher risk of adverse effects with antiarrhythmic drugs in HF patients. As such, catheter ablation for atrial fibrillation in patients with heart failure with reduced ejection fraction has been increasingly explored as a treatment modality. We review the contemporary evidence regarding patient selection, efficacy, safety, and impact of catheter ablation on outcomes in patients with atrial fibrillation and heart failure with reduced ejection fraction.
Keyphrases
- catheter ablation
- atrial fibrillation
- heart failure
- left atrial
- left atrial appendage
- oral anticoagulants
- ejection fraction
- direct oral anticoagulants
- end stage renal disease
- acute heart failure
- percutaneous coronary intervention
- left ventricular
- newly diagnosed
- chronic kidney disease
- cardiac resynchronization therapy
- case report
- peritoneal dialysis
- blood pressure
- coronary artery disease
- type diabetes
- acute coronary syndrome
- heart rate
- case control
- combination therapy
- replacement therapy
- venous thromboembolism